论文部分内容阅读
恶性淋巴瘤在病程进展中出现原始淋巴细胞者,称淋巴瘤侵犯骨髓合并白血病。恶性淋巴瘤合并白血病是具有独特临床表现及细胞形态的一种特殊类型白血病。其发病率的高低,与病理类型,原发部位,临床分期有关。如何提高生存率,则与合理治疗有密切关系。我们采用以瘤可宁为主的联合化疗(瘤可宁、氮芥、长春新硷、强的松),简称BMOP方案,取得较明显的疗效。下面结合文献,就其临床持点,以及生存期略作探讨。
Malignant lymphoma in the course of progress in the presence of primitive lymphocytes, lymphoma invading bone marrow associated with leukemia. Malignant lymphoma with leukemia is a special type of leukemia with unique clinical manifestations and cell morphology. The incidence of high and low, and the pathological type, primary site, clinical stage related. How to improve the survival rate, then with reasonable treatment are closely related. We use to tumor Ning based chemotherapy (tumor Ning, mechlorethamine, vincristine, prednisone), referred to as BMOP program, achieved more significant effect. The following combination of literature on its clinical point, as well as a brief discussion of survival.